Frontlight ResearchEarly access
Head and neck cancer trials in China
216 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in ChinaNeoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 45
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06699498 - Phase 3Taking peopleA Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
- Where
- Chengdu, Wuhan
- Age
- 18 years to 75 years
- People
- 510
- Run by
- Akeso
See details and how to joinNCT06601335 - Phase 2Taking peopleSBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 35
- Run by
- Sun Yat-sen University
See details and how to joinNCT06611137 - Phase 1Taking peopleU87 CAR-T in Patients With Advanced Head and Neck Tumors
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 20
- Run by
- Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
See details and how to joinNCT06614686 - No phaseTaking peopleEffects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
- Where
- Guanzhou
- Age
- 18 years to 80 years
- People
- 302
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06575322 - Phase 1/2Taking peopleDe-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC
- Where
- Shanghai
- Age
- 18 years and over
- People
- 20
- Run by
- Ruijin Hospital
See details and how to joinNCT06572514 - Phase 2Taking peopleARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Where
- Beijing, Changsha, Chengdu, Dalian, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Nanning, Shanghai, Shenyang, Tianjin, Wuhan, Xi’an, Xinjiang, Zhengzhou, Zhuhai
- Age
- 18 years and over
- People
- 170
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT06007729 - Phase 2Not yet taking people in ChinaTislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer
- Where
- Zhengzhou
- Age
- 18 years to 70 years
- People
- 46
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06554028 - Phase 2Taking peopleEfficacy and Safety of PD-1 Plus Chemotherapy in Poorly Differentiated Locally Advanced (LA) HNSCC
- Where
- Beijing
- Age
- 18 years and over
- People
- 100
- Run by
- Beijing Tongren Hospital
See details and how to joinNCT06100497 - Phase 2Taking peopleMilaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
- Where
- Hangzhou
- Age
- 18 years to 65 years
- People
- 260
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT06534762 - Phase 2/3Taking peopleTrans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
- Where
- Guanzhou
- Age
- 18 years and over
- People
- 200
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT03755739 - Phase 1/2Taking peopleTriplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 100
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05187338 - No phaseTaking peopleGDFT on the Postoperative Outcome in Head and Neck Cancer Surgery
- Where
- Beijing
- Age
- 18 years and over
- People
- 340
- Run by
- Beijing Tongren Hospital
See details and how to joinNCT06468852 - Phase 2Taking peopleDe-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 103
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06353685 - Phase 3Taking peopleTislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)
- Where
- Guanzhou, Shenzhen, Zhongshan
- Age
- 18 years to 80 years
- People
- 537
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05582265 - Phase 2Taking peopleTislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 154
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06323369 - Phase 2Taking peopleResponse Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 133
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06345287 - Phase 2Taking peopleNeoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 43
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05098119 - Phase 2Taking peopleSBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 25
- Run by
- Sun Yat-sen University
See details and how to joinNCT06219980 - Phase 2Taking peopleNeoadjuvant SBRT in Localized Advanced HNSCC
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 81
- Run by
- Jiang Feng
See details and how to joinNCT06306846 - No phaseTaking peoplePlasma SAA1 Levels in Predicting Response to Radiotherapy-induced Oral Mucositis
- Where
- Fuzhou, Guangzhou, Huizhou, Jieyang, Meizhou
- Age
- 18 years and over
- People
- 300
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT06307314 - Phase 2Not yet taking people in ChinaMyeloprotection With Trilaciclib in Pan-cancer Population
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 132
- Run by
- Sun Yat-sen University
See details and how to joinNCT06297811 - Phase 2Taking peopleA Prospective Randomized Controlled Study of Immune Checkpoint Maintenance Therapy After Radiotherapy and Chemotherapy for Locally Advanced Head and Neck Tumors Based on Peripheral Blood CD8Tex Detection in Peripheral Blood
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 104
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06240689 - Phase 1Taking peopleHRYZ-T101 Injection for HPV18 Positive Solid Tumor
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 32
- Run by
- HRYZ Biotech Co.
See details and how to joinNCT05952947 - Phase 2Taking peoplePostoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC
- Where
- Beijing
- Age
- 18 years to 70 years
- People
- 173
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06170710